By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomodels said today that Swedish Orphan Biovitrum has contracted it to test the possibility of developing a predictive assay to determine which stem cell therapy patients may be at risk for a complication called oral mucositis.

Under the agreement, the Watertown, Mass.-based preclinical drug research firm aims to develop a screening platform to define mucositis risk for patients undergoing conditioning regimens for hematopoietic stem cell transplants (HSCT).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.